Company GeneNews Ltd Toronto S.E.
Equities
CA36870T2065
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Clinical Consultation
79.7
%
| - | - | 4 | 79.7 % | - |
Laboratory Testing
20.3
%
| - | - | 1 | 20.3 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
70.0
%
| - | - | 3 | 70.0 % | - |
Western Europe
30.0
%
| - | - | 1 | 30.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/02/01 | |
Rebecca Greco
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01/98/01 |
Garth MacRae
BRD | Director/Board Member | 90 | 01/00/01 |
Chief Executive Officer | - | 01/02/01 | |
Harry Glorikian
BRD | Director/Board Member | 58 | 01/08/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 123,532,981 | 98,370,853 ( 79.63 %) | 0 | 79.63 % |
Company contact information
StageZero Life Sciences Ltd.
70 East Beaver Creek Road Unit 30
L4B 3B2, Richmond Hill
+
http://www.stagezerolifesciences.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+28.65% | 4.82TCr | |
-0.38% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+10.85% | 2.56TCr | |
-22.69% | 1.9TCr | |
+8.85% | 1.29TCr | |
+30.22% | 1.2TCr | |
-1.54% | 1.18TCr |